Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 98

    1.

    Recombinant tissue plasminogen activator injected into the vitreous cavity may penetrate the retinal veins of a porcine model of vascular occlusion.

    Mahmoud TH, Peng YW, Proia AD, Davidson M, Deramo VA, Fekrat S.

    Br J Ophthalmol. 2006 Jul;90(7):911-5. Epub 2006 Mar 15.PMID: 16540487 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    Increased retinal toxicity of intravitreal tissue plasminogen activator in a central retinal vein occlusion model.

    Yamamoto T, Kamei M, Kunavisarut P, Suzuki M, Tano Y.

    Graefes Arch Clin Exp Ophthalmol. 2008 Apr;246(4):509-14. Epub 2007 Oct 25.PMID: 17960414 [PubMed - indexed for MEDLINE]Related articles

    3.

    A study of the ability of tissue plasminogen activator to diffuse into the subretinal space after intravitreal injection in rabbits.

    Kamei M, Misono K, Lewis H.

    Am J Ophthalmol. 1999 Dec;128(6):739-46.PMID: 10612511 [PubMed - indexed for MEDLINE]Related articles

    4.

    Retinal vein cannulation with prolonged infusion of tissue plasminogen activator (t-PA) for the treatment of experimental retinal vein occlusion in dogs.

    Tameesh MK, Lakhanpal RR, Fujii GY, Javaheri M, Shelley TH, D'Anna S, Barnes AC, Margalit E, Farah M, De Juan E Jr, Humayun MS.

    Am J Ophthalmol. 2004 Nov;138(5):829-39.PMID: 15531319 [PubMed - indexed for MEDLINE]Related articles

    5.

    Basic fibroblast growth factor stimulates 3H-thymidine uptake in retinal venular and capillary endothelial cells in vivo.

    de Juan E, Stefansson E, Ohira A.

    Invest Ophthalmol Vis Sci. 1990 Jul;31(7):1238-44.PMID: 2365555 [PubMed - indexed for MEDLINE]Related articlesFree article

    6.

    A study of retinal penetration of intravitreal tenecteplase in pigs.

    Kwan AS, Vijayasekaran S, McAllister IL, Yu PK, Yu DY.

    Invest Ophthalmol Vis Sci. 2006 Jun;47(6):2662-7.PMID: 16723484 [PubMed - indexed for MEDLINE]Related articlesFree article

    7.

    Effect of triamcinolone acetonide on vascular endothelial growth factor and occludin levels in branch retinal vein occlusion.

    McAllister IL, Vijayasekaran S, Chen SD, Yu DY.

    Am J Ophthalmol. 2009 May;147(5):838-46, 846.e1-2. Epub 2009 Feb 10.PMID: 19211093 [PubMed - indexed for MEDLINE]Related articles

    8.

    [Experiment study of infusing tPA in retinal vein for treatment of retinal vein occlusion]

    Hu YT, Ma ZZ, Zhang XL, Han SY, Huang LJ.

    Zhonghua Yan Ke Za Zhi. 2003 Nov;39(11):645-9. Chinese. PMID: 14766057 [PubMed - indexed for MEDLINE]Related articles

    9.

    Retinal toxicity of commercial intravitreal tissue plasminogen activator solution in cat eyes.

    Hrach CJ, Johnson MW, Hassan AS, Lei B, Sieving PA, Elner VM.

    Arch Ophthalmol. 2000 May;118(5):659-63.PMID: 10815158 [PubMed - indexed for MEDLINE]Related articles

    10.

    Retinal toxicity of recombinant tissue plasminogen activator in the rabbit.

    Johnson MW, Olsen KR, Hernandez E, Irvine WD, Johnson RN.

    Arch Ophthalmol. 1990 Feb;108(2):259-63.PMID: 2105712 [PubMed - indexed for MEDLINE]Related articles

    11.

    Effect of squalamine on iris neovascularization in monkeys.

    Genaidy M, Kazi AA, Peyman GA, Passos-Machado E, Farahat HG, Williams JI, Holroyd KJ, Blake DA.

    Retina. 2002 Dec;22(6):772-8.PMID: 12476105 [PubMed - indexed for MEDLINE]Related articles

    12.

    Safety of in vivo pharmacologic vitreolysis with recombinant microplasmin in rabbit eyes.

    Sakuma T, Tanaka M, Mizota A, Inoue J, Pakola S.

    Invest Ophthalmol Vis Sci. 2005 Sep;46(9):3295-9.PMID: 16123432 [PubMed - indexed for MEDLINE]Related articlesFree article

    13.

    Tissue plasminogen activator in the treatment of experimental retinal vein occlusion.

    Oncel M, Peyman GA, Khoobehi B.

    Retina. 1989;9(1):1-7.PMID: 2497501 [PubMed - indexed for MEDLINE]Related articles

    14.

    Injection of tissue plasminogen activator into a branch retinal vein in eyes with central retinal vein occlusion.

    Weiss JN, Bynoe LA.

    Ophthalmology. 2001 Dec;108(12):2249-57.PMID: 11733266 [PubMed - indexed for MEDLINE]Related articles

    15.

    Intravitreal tissue plasminogen activator for acute central retinal vein occlusion.

    Lahey JM, Fong DS, Kearney J.

    Ophthalmic Surg Lasers. 1999 Jun;30(6):427-34.PMID: 10392729 [PubMed - indexed for MEDLINE]Related articles

    16.

    Intravitreal injection of tissue plasminogen activator for central retinal vein occlusion.

    Elman MJ, Raden RZ, Carrigan A.

    Trans Am Ophthalmol Soc. 2001;99:219-21; discussion 222-3.PMID: 11797310 [PubMed - indexed for MEDLINE]Related articlesFree article

    17.

    Internal limiting membrane ablation in pig eyes with the Er:YAG laser under perfluorodecalin.

    Janknecht P, Feltgen N, Wesendahl T, Wiek J, Eissner B, Ott B, Staubach F, Frenz M.

    Graefes Arch Clin Exp Ophthalmol. 2001 Sep;239(9):705-11.PMID: 11688672 [PubMed - indexed for MEDLINE]Related articles

    18.

    Hemodynamic response to intravitreal triamcinolone in eyes with macular edema: intravitreal triamcinolone and ocular blood flow.

    Cekiç O, Bardak Y, Tiğ SU, Demirkol A, Ekim MM, Altintaş O, Yeşildağ A, Oyar O.

    Int Ophthalmol. 2007 Oct;27(5):313-9. Epub 2007 May 16.PMID: 17505781 [PubMed - indexed for MEDLINE]Related articles

    19.

    Indocyanine green as useful guide for retinal vein cannulation and injection of tissue plasminogen activator in rabbits.

    Suzuki K, Suzuki Y, Mizukoshi S, Metoki T, Nakazawa M.

    Tohoku J Exp Med. 2008 Apr;214(4):351-8.PMID: 18441511 [PubMed - indexed for MEDLINE]Related articlesFree article

    20.

    Management of acute submacular hemorrhage using recombinant tissue plasminogen activator and gas.

    Hesse L, Schmidt J, Kroll P.

    Graefes Arch Clin Exp Ophthalmol. 1999 Apr;237(4):273-7.PMID: 10208258 [PubMed - indexed for MEDLINE]Related articles

    Supplemental Content

    Find related data